Lung Cancer Screening Does Not Increase Unnecessary Surgery Rates
the ONA take:
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses and a rare incidence of surgical intervention for benign disease, a new study published in the journal The Annals of Thoracic Surgery has shown.
For the study, researchers at Lahey Hospital & Medical Center retrospectively analyzed the surgical outcomes of 25 of the 1,654 patients who underwent low-dose computer tomography lung cancer screening.
Results showed that of the 25 that underwent surgery, five had non-lung cancer diagnoses, equating to an incidence of surgery for non-lung cancer diagnosis of 0.30%.
Researchers found that the incidence of surgery for benign disease was 0.24%. The other 20 patients had lung cancer, of which 18 had early stage disease and two had late stage disease.
“Lung cancer screening saves lives, and our study serves as a model for how to set up a screening program that is safe and effective for patients,” said Christina Williamson, MD, from Lahey Hospital & Medical Center.
“It is only by minimizing the number of operations for benign disease and maintaining a low morbidity and mortality for surgical resection that the full benefit of lung cancer screening can be realized in its widespread adoption in clinical practice,” Williamson said.
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|